Leister Nicolas, Wendt Stefanie, Hedergott Andrea, Heindl Ludwig M, Rokohl Alexander C, Stoll Sandra E, Gordon Erik, Böttiger Bernd W, Fricke Julia, Schick Volker C
Department of Anaesthesiology and Intensive Care Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Köln, Germany.
Department of Cardiothoracic Surgery and Intensive Care Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937 Köln, Germany.
J Clin Med. 2024 Aug 11;13(16):4710. doi: 10.3390/jcm13164710.
Chronic progressive external ophthalmoplegia (CPEO) belongs to the group of mitochondrial encephalomyopathies. Anaesthesia for patients with CPEO may be associated with an increased risk due to known drug effects on mitochondrial metabolism. Therefore, the aim of this analysis was to evaluate anaesthesiological concepts in patients with CPEO requiring ophthalmic surgery.
This is a retrospective, monocentric cohort analysis of eleven patients with CPEO undergoing ophthalmic surgery either with general anaesthesia or local anaesthesia in a German university hospital from January 2012 to February 2022.
A total of twelve ophthalmic surgery procedures were performed in eleven adult patients with CPEO. Six patients underwent surgery after receiving local anaesthesia (LA cohort). Five patients underwent six surgical procedures under general anaesthesia (GA cohort). In five cases within the GA cohort, propofol and remifentanil were used for the maintenance of anaesthesia. In one case, balanced anaesthesia with desflurane and remifentanil was used. The median duration of general anaesthesia was 37.5 min (range, 25-65 min). Patients stayed in the recovery room for a median of 48.5 min (range, 35-70 min). All patients were discharged on the first postoperative day. No relevant complications occurred in either the LA or GA cohort.
Both local and general anaesthesia are feasible concepts for patients with CPEO undergoing ophthalmic surgery. Propofol, at least with a short duration (less than one hour) of use, appears to be a feasible hypnotic drug in CPEO patients.
慢性进行性眼外肌麻痹(CPEO)属于线粒体脑肌病范畴。由于已知药物对线粒体代谢有影响,CPEO患者的麻醉可能会增加风险。因此,本分析的目的是评估需要眼科手术的CPEO患者的麻醉方案。
这是一项回顾性、单中心队列分析,对2012年1月至2022年2月在德国一家大学医院接受全身麻醉或局部麻醉的11例CPEO患者进行眼科手术。
11例成年CPEO患者共进行了12台眼科手术。6例患者在接受局部麻醉后接受手术(局部麻醉组)。5例患者在全身麻醉下接受了6台手术(全身麻醉组)。在全身麻醉组的5例手术中,使用丙泊酚和瑞芬太尼维持麻醉。在1例手术中,使用地氟醚和瑞芬太尼进行平衡麻醉。全身麻醉的中位持续时间为37.5分钟(范围25 - 65分钟)。患者在恢复室的中位停留时间为48.5分钟(范围35 - 70分钟)。所有患者均在术后第一天出院。局部麻醉组和全身麻醉组均未发生相关并发症。
局部麻醉和全身麻醉对于接受眼科手术的CPEO患者都是可行的方案。丙泊酚,至少在短时间(少于1小时)使用时,似乎是CPEO患者可行的催眠药物。